125 related articles for article (PubMed ID: 7528850)
1. Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study.
Chen X; Borggrefe M; Martinez-Rubio A; Hief C; Haverkamp W; Hindricks G; Breithardt G
J Cardiovasc Pharmacol; 1994 Oct; 24(4):664-9. PubMed ID: 7528850
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Ludmer PL; McGowan NE; Antman EM; Friedman PL
J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970
[TBL] [Abstract][Full Text] [Related]
3. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
Hammill SC; McLaran CJ; Wood DL; Osborn MJ; Gersh BJ; Holmes DR
J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia.
Rowland E; McKenna WJ; Krikler DM
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1513-9. PubMed ID: 3873867
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
Manz M; Steinbeck G; Lüderitz B
Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome.
Dubuc M; Kus T; Campa MA; Lambert C; Rosengarten M; Shenasa M
Am Heart J; 1989 Feb; 117(2):370-6. PubMed ID: 2644795
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
[TBL] [Abstract][Full Text] [Related]
8. A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome.
O'Nunain S; Garratt CJ; Linker NJ; Gill J; Ward DE; Camm AJ
Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):2028-34. PubMed ID: 1721219
[TBL] [Abstract][Full Text] [Related]
9. [Electrophysiological effects of intravenous propafenone for treating atrial-ventricular nodal dual pathways reentrant tachycardia].
Shi L; Qian JA; Qi WH
Zhonghua Nei Ke Za Zhi; 1992 Oct; 31(10):609-10, 657. PubMed ID: 1306450
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
Chen SA; Chiang CE; Tai CT; Lee SH; Chiou CW; Ueng KC; Wen ZC; Cheng CC; Chang MS
Circulation; 1996 Jun; 93(11):2023-32. PubMed ID: 8640978
[TBL] [Abstract][Full Text] [Related]
11. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
12. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
[TBL] [Abstract][Full Text] [Related]
13. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
Manz M; Beermann J; Gerckens U; Lüderitz B
Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
[TBL] [Abstract][Full Text] [Related]
14. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
Jackman WM; Friday KJ; Fitzgerald DM; Yeung-Lai-Wah JA; Lazzara R
Am J Cardiol; 1988 Dec; 62(19):8L-19L. PubMed ID: 3059792
[TBL] [Abstract][Full Text] [Related]
15. [Acute effects of propafenone in patients with ventricular pre-excitation].
Maia IG; Cruz Filho F; Fagundes ML; Loyola LH; Pimenta J; Lorga AM
Arq Bras Cardiol; 1993 Jul; 61(1):23-6. PubMed ID: 8285860
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects, efficacy and safety of intravenous propafenone in termination of atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia: a prospective non-randomized interventional study.
Pintarić H; Manola S; Nossan JS; Pavlović N; Delić-Brkljacić D; Radeljić V
Acta Clin Croat; 2010 Mar; 49(1):25-31. PubMed ID: 20635581
[TBL] [Abstract][Full Text] [Related]
17. Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
Brugada P; Dassen WR; Braat S; Gorgels AP; Wellens HJ
Am J Cardiol; 1983 Jul; 52(1):70-2. PubMed ID: 6858931
[TBL] [Abstract][Full Text] [Related]
18. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation].
Fauchier JP; Cosnay P; Moquet B; Rouesnel P; Kapusta P; Vrancea F
Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1506-14. PubMed ID: 3099684
[TBL] [Abstract][Full Text] [Related]
19. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A
Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
